Endocrino-Immuno-Senescence And Its Correlation With Age-Related Diseases: Molecular Insights Into Immunomodulatory Strategies For Healthy Aging

Aging Theory
Aging Pathway
Therapeutic
The paper highlights that the aging process leads to a decline in both the endocrine and immune systems, a condition termed endocrino-immuno-senescence, which contributes to various age-related diseases, and suggests immunomodulatory strategies as potential therapeutic approaches for healthy aging.
Author

Gemini

Published

August 14, 2026

As we age, our bodies undergo significant changes, and two crucial systems—our hormonal system (endocrine system) and our defense system (immune system)—begin to decline in their efficiency. This interconnected weakening is a key factor in why we become more susceptible to various health problems as we get older.

This age-related decline, often referred to as “endocrino-immuno-senescence,” means that our hormones are less balanced, and our immune cells are less effective at fighting off invaders or repairing damage. This leads to a state where our immune system becomes less capable of protecting us, a process called “immunosenescence.”

Compounding this issue is “inflammaging,” a chronic, low-grade inflammation that persists throughout the body as we age. This constant inflammation further damages tissues and organs, accelerating the development of conditions like infections, autoimmune disorders, and even cancer.

Understanding these complex interactions is vital because they are at the root of many age-related diseases. The good news is that researchers are exploring “immunomodulation” as a promising strategy. This involves interventions aimed at rebalancing and strengthening the immune system to counteract the negative effects of aging. By preserving hormonal stability and enhancing immune responses, we may be able to mitigate age-related health disparities and promote healthier, more vibrant aging.


Source: link to paper